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Abstract
Inhalation injury causes a heterogeneous cascade of insults that increase morbidity and mortality 
among the burn population. Despite major advancements in burn care over the last several 
decades, there remains a significant burden of disease attributable to inhalation injury. For this 
reason effort has been devoted to find new therapeutic approaches to improve outcomes for 
patients who sustain inhalation injuries.
The three major injury classes are: supraglottic, subglottic, and systemic. Treatment options 
between these three subtypes differ based on the pathophysiologic changes that each one elicits.
Currently, no consensus exists for diagnosis or grading of the injury and there are large variations 
in treatment worldwide, ranging from observation and conservative management to advanced 
therapies with nebulization of different pharmacologic agents.
The main pathophysiologic change after a subglottic inhalation injury is an increase in the 
bronchial blood flow. An induced mucosal hyperemia leads to edema, increases mucus secretion 
and plasma transudation into the airways, disables the mucociliary escalator, and inactivates 
hypoxic vasocontriction. Collectively, these insults potentiate airway obstruction with casts formed 
from epithelial debris, fibrin clots, and inspissated mucus. resulting in impaired ventilation. 
Prompt bronchoscopic diagnosis and multimodal treatment improves outcomes. Despite the lack 
of globally acceptedstandard treatments, data exist to support the use of bronchoscopy and 
suctioning to remove debris, nebulized heparin for fibrin casts, nebulized n-acetylcysteine for 
mucus casts, and bronchodilators.
Systemic effects of inhalation injury occur both indirectly from hypoxia or hypercapnia resulting 
from loss of pulmonary function and systemic effects of pro-inflammatory cytokines, as well as 
direct effects from metabolic poisons such as carbon monoxide and cyanide. Both present with 
non-specific clinical symptoms including cardiovascular collapse. Carbon monoxide intoxication 
should be treated with oxygen and cyanide with hydroxocobalamin.
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Inhalation injury remains a great challenge for clinicians and an area of opportunity for scientists. 
Management of this concomitant injury lags behind other aspects of burn care. More clinical 
research is required to improve the outcome of inhalation injury.
The goal of this review is to comprehensively summarize the diagnoses, treatment options, and 
current research.
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Introduction
A serious clinical entity, inhalation injury augments morbidity and increases the probability 
of death. There is a lack of a consensus diagnostic criteria and grading of the severity, and 
there is no standardized treatment that reduces morbidity and mortality in these patients.
In the United States, 486,000 burn patients received medical treatment in 2016.1 3,275 died 
as a result of their injuries. Fire and inhalation casualties are combined in this total; deaths 
from thermal burns cannot always be distinguished from fatalities resulting from the 
inhalation of smoke and toxins. The National Burn Repository of the American Burn 
Association reports up to 10.3% of the burn patients have concomitant inhalation injury.2,3 
As such, 1 in 10 burn patients surviving to admission will have the inhalation injury with the 
respective increase in the mortality rate.
Of 40,000 hospital admissions from burn injuries, only 30,000 were at burn centers;2,3 
10,000 patients with burns severe enough to meet hospitalization criteria were treated at 
non-burn centers. This implies the care received was not specialized, and possibly the 
treatment was not optimal. When treating inhalation injury, the care should be as specialized 
and as current as possible.
The pulmonary system has three fundamental functions: ventilation, oxygenation, and 
expectoration. The duration of smoke exposure, temperature of the inhaled smoke, and 
composition of the smoke are determinants of injury severity.4 Inhalation injury is a 
composite of multiple insults including: supraglottic thermal injury, subglottic airway and 
alveolar poisoning, and systemic poisoning from absorbed small molecule toxins. These 
contaminant insults independently affect each of the pulmonary functions as well as having a 
direct effect on systemic physiology. Further, anatomic characteristics can predispose 
patients to inhalation injury. For example, an infant will develop airway obstructions much 
faster than an adult due to reduced airway diameter. Understanding the contributions of each 
of these pathologies to the patient’s disease is critical to managing inhalation injury.
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Pathophysiology
Supraglottic
Thermal injury is usually confined to the supraglottis due to low heat capacity of air and 
efficient heat dissipation in the upper airway as well as the protective effect of the glottis, 
which tends to close and prevent heat from reaching the infraglottic area.5,6 The edema 
resulting from injury to the supraglottic structures can obstruct the upper airway just hours 
following insult.7 This upper airway edema and obstruction-compromised ventilation can 
progress quickly with burn edema during resuscitation7.
Subglottic
With the exception of inhaled steam, injury below the glottis is largely chemically derived 
arising from the inhalation of irritants and noxious chemicals, such as halogen acids, 
unsaturated aldehydes, and formaldehyde, inflicting damage through direct injury as well as 
through neurogenic inflammation.8 The materials on fire determine the composition of the 
smoke and the severity of the inflammatory reactions. These provoke a violent response 
from the lung parenchyma. The principle subglottic pathophysiologic changes occurring 
after inhalation injury are: airway mucosal hyperemia, bronchospasm, and cast formation 
from fibrinous exudation into the airways, mucosal sloughing, inspissated mucus, and loss 
of surfactant and mucociliary escalator function.7
To start, chemical irritants and smoke entering the lungs incite production of neuropeptides 
that trigger a major inflammatory response characterized by activation of the vagal nerve 
sensory C-fibers, which contain pro-inflammatory peptides, neurokinins, and calcitonin 
gene-related peptide.9,10 Neural endopeptidase targets neuropeptides and plays an important 
role in pathophysiologic changes.11 This leads to bronchoconstriction and activation of nitric 
oxide synthase (iNOS) that generates reactive oxygen species and inhibits hypoxic 
pulmonary vasoconstriction.12–14 Increased airway blood flow is the main factor underlying 
pathologic changes. Dysregulation of hypoxic pulmonary vasoconstriction causes a right-to-
left shunting of deoxygenated blood and, thus, systemic hypoxemia. Irritation also results in 
bronchospasm and impairment of gas exchange in distal airways.7 Edema results as a 
secondary consequence of the activation of the inflammatory cascade.15–18 These 
pathologies lead to small airway obstruction, including alveoli, and compromise ventilation, 
leading to ventilation/perfusion (V/Q) mismatching, causing intrapulmonary shunting and, 
ultimately, compromising oxygenation. Hypermetabolism and the systemic inflammatory 
response are much more intense when inhalation injury is accompanied by cutaneous burn.19
Airway mucosal hyperemia begins rapidly after inhalation injury. Following inhalation 
injury, circulation to the right main bronchus increases up to 20-fold.20 This hyperemia 
provides some physical narrowing of the airways. More significantly, airway hyperemia 
promotes edema and airway exudation, which together diminish effective airway space 
through the formation of fibrin and mucus casts inside the alveoli, compromising 
oxygenation. Due to augmented bronchial blood flow, microvascular pressure and capillary 
permeability increase while the plasma protein concentration in the intravascular space 
decreases. As a result, there is an increase in transvascular fluid flux (lymph flow).21
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The etiology of bronchospasm after inhalation injury is unclear, though it may be due to the 
release of neuropeptides, which are synthesized in the airway submucosa. The degree of 
spasm depends on the compounds present in the inhaled smoke as well as individual airway 
sensitivity to the chemical irritants and toxins.22–25 The bronchospasm serves to exacerbate 
the small airway narrowing initiated by airway mucosal hyperemia. This is intensified by the 
compromised surfactant function that promotes alveolar collapse and atelectasis.
Narrowed airways are ultimately obstructed by airway casts. Airway casts form from blood 
clots, mucus, and sloughed pulmonary epithelium unable to be expectorated due to impaired 
mucociliary escalator function. They adhere to the airway wall, reducing luminal space and 
compromising ventilation. Casts can also obstruct endotracheal cannula. Casts tend to 
migrate to lower airways due to gravity, and this, combined with impaired ciliary function, 
produces hypoventilation of the alveoli and shunting, leading to systemic hypoxia. In an 
inhalation injury animal model, almost 100% of the epithelial airway cells were sloughed 
within 24 hours after the insult.26 Additionally, the increase in blood flow to the bronchi and 
consequently to the bronchial mucus glands stimulates mucus secretion. Excessive mucus in 
the context of impaired ciliary function to clear it leads to the formation of obstructive 
airway casts and their deleterious effects.27 Airway obstruction is life-threatening, and even 
the obstruction of some proximal bronchi can cause hypoventilation of an entire pulmonary 
segment.28 Further, the loss of the epithelial integrity in addition to impaired cell function in 
the airway diminishes bacterial clearance, either through ciliary dysfunction or impaired 
phagocytosis. These issues raise the risk of acquiring an infection of the airway and lungs. 
Failure to expectorate casts and secretions following inhalation injury can be dangerous and 
lethal by compromising ventilation and causing shunting that embarrasses oxygenation.29
When casts obstruct areas of the injured lung, tidal volumes redistribute to non-obstructed 
areas. This injures the non-obstructed, functional lung with volutrauma, barotrauma, Acute 
Respiratory Distress Syndrome (ARDS), and pneumothorax.30 These additional insults to 
the airway increase its susceptibility to infections and permit migration of inflammatory 
cells into the airway, obstructing alveoli and increasing capillary permeability. This cycle 
leads to further plasma leak and pulmonary edema, impairing the ventilation/oxygenation 
ratio and creating right-to-left shunting.31 Additionally, casts originate the chain reaction 
culminating in an intense and generalized inflammation response capable of affecting every 
organ.32 Insufficient oxygen in the body is an independent factor for the release of several 
cytokines that have proinflammatory effects.33,34 Proinflammatory mediators and reactive 
oxygen species, which also result from administration of oxygen in excess of 60% for more 
than 6 hours, contribute to tissue destruction and organ dysfunction.35–40
The small airway obstructions caused by mucosal hyperemia, bronchospasm, epithelial and 
ciliary loss, and the formation of obstructive casts collectively conspire to compromise 
ventilation, oxygenation, and expectoration in the subglottic component of inhalation injury.
ARDS—Any discussion of the pathophysiology of subglottic inhalation injury must include 
ARDS as it is a potentially terminal end point. It typically does not develop until 4–8 days 
postburn. ARDS is the most severe form of acute lung injury that leads to acute respiratory 
failure and is commonly followed by multisystem organ failure and death.41 Annually, 
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nearly 200,000 patients are diagnosed with ARDS in the United States,42 with a mortality 
rate reaching 36%.43 Severe burns associate with hypoxemia and the development of ARDS. 
Clinical manifestations of ARDS include pulmonary edema, inability to ventilate and 
eliminate carbon dioxide, and marked and severe arterial hypoxemia. If the patient is 
conscious and not intubated, tachypnea and dyspnea will be prominent. As per the 
American-European Consensus Conference, the diagnostic criterion was a PaO2/FiO2 ratio ≤ 
200 mmHg.43 The newer Berlin definition characterizes ARDS as acute, within one week of 
a clinical event not explained by cardiac failure, or fluid overload and associated with a 
positive end-expiratory pressure of ≥ 5 cmH20. ARDS is categorized as mild with a 
PaO2/FiO2 between 200–300, moderate between 100–200, and severe below 100.44–46
Inflammation products (e.g., cytokines and coagulation system products) are theorized to 
induce the alterations representative of ARDS.47 The influx of protein-rich edema fluid into 
air spaces consequent of increased permeability of the alveolar–capillary barrier and 
endothelial injury distinguishes the acute phase of ARDS. Intriguingly, it was demonstrated 
that the severity of inhalation injury does not correlate to the elaboration of ARDS in burned 
patients.48 While the pathology of smoke inhalation begins proximally in the airways and 
decreases in effect deeper into the lung, the damage in ARDS begins distally in the alveoli 
and diminishes as it proceeds proximally. Smoke inhalation and ARDS are two distinct but 
related conditions.
Systemic Injury
The pulmonary damage of an inhalation injury has direct systemic pathophysiology 
including hypoxemia, hypercapnia, acidosis, and systemic inflammation from the myriad of 
inflammatory mediators elaborated from the lung. Soluble products of combustion, such as 
carbon monoxide (CO) and cyanide, serve as direct poisons. CO preferentially binds Fe2+ in 
hemoglobin compromising tissue oxygenation. Cyanide prefers binding Fe3+ in the 
mitochondrial cytochromes compromising oxygen utilization and oxidative phosphorylation. 
These small molecular toxins result from similar combustion processes, occur 
coincidentally, and act synergistically.
Diagnosis
No consensus exists regarding the diagnosis, grading, and prognosis of inhalation injury.49 
Lack of diagnostic consensus may result from delayed presentation. Full manifestation 
occurs up to 48 hours after the inhalation insult once the inflammation reaches its peak. 
Further, the clinical presentation (degree of respiratory failure) may not correspond with the 
intensity of the exposure.50,51 In fact, acute lung injury can develop in patients who sustain 
large cutaneous burns without inhalation injury due to the intense and severe inflammatory 
response extensive burns elicit in burn patients.52 For instance, patients with a considerable 
total body surface area (TBSA) burn by scald may develop acute lung injury.53 Most patients 
with inhalation injury who arrive early to the emergency room are conscious with a patent 
airway, and the initial chest radiograph and arterial blood gases may appear at most only 
slightly abnormal.54 As a result of non-specific or delayed presentations, various diagnostic 
adjuncts are utilized worldwide.
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Findings of a physical exam that can indicate inhalation injury include: sooty sputum, 
stridor, wheezing, facial burns, singed nasal hairs, anxiety, cough, stupor, signs of 
hypoxemia, and dyspnea7,8,30,55–57. However, physical findings alone can be misleading and 
should be used in conjunction with other diagnostic adjuncts. One study reported that while 
70% of inhalation injury patients present with facial burns, 70% of patients with facial burns 
do not incur significant pulmonary injury58. Useful injury history that ought be obtained at 
admission includes estimated time of exposure, type of burning material(s), location of 
injury (e.g., enclosed structure, bonfire), and any changes in mental status.7
Supraglottic Injury
Supraglottic injuries are diagnosed on direct visual examination and are often apparent on 
physical examination. Indirect laryngoscopy permits visual assessment to the level of the 
vocal cords and can be a useful, albeit limited, tool should bronchoscopy be unavailable to 
the clinician.59 Notably, ingesting scalding liquids can produce oropharyngeal scald burns. 
These may lead to the development of edema that can occlude the airway with fatal 
consequences, clinically resembling an edematous epiglottitis.60
Subglottic Injury
While some clinicians rely on a physical examination and the accident history for diagnosis, 
these are relatively subjective as compared to bronchoscopy.51 A diagnostic adjunct for 
acute inhalation injury since 1975,61 fiberoptic (flexible) bronchoscopy (FOB) is still not 
universally available, though it is widely used because it provides an immediate view of the 
airway and is reliable for making a rapid diagnosis of inhalation injury and grading it. As the 
gold standard for diagnosis, FOB permits direct visualization of both supraglottic and 
subglottic structures and allows assessment of airway tissue damage from temperature or 
noxious chemical gases.62 Most importantly, while performing the bronchoscopy, the 
clinician can decide if the patient requires intubation.63 Positive findings of inhalation injury 
from bronchoscopy include: erythema, edema (which may be seen as a blunting of the 
carina), mucosal blisters, erosions, hemorrhages, bronchial secretions, and soot deposits 
(Figure 1).7,8 As Hunt and colleagues noted, the airway may appear normal and show no 
signs of mucosal injury, particularly when bronchoscopy is performed very early after the 
inhalation incident.61 Another factor confounding diagnosis is that extensive cutaneous 
burns elicit a major inflammatory response. Resultantly, acute lung injury and 
tracheobronchitis may be seen 48 hours post-burn but are unrelated to inhalation injury. 
Therefore, the physician should supplement the bronchoscopy with physical examination 
and history of the mechanism of injury to ascertain if inhalation injury is present. Due to the 
heat transfer process, greater tissue damage can be expected at proximal sites than at distal 
ones.64
Additional diagnostic techniques have been developed and tested; however, these have not 
been incorporated into standard care protocols because they are too expensive, not readily 
available worldwide, or do not provide enough information to justify the cost. Xenon-133 
scan is a sensitive tool for the diagnosis of inhalation injury.58 This useful adjunct can assess 
the condition of the terminal airways. Various studies have shown that when used in 
conjunction with FOB or with FOB and pulmonary function tests, diagnoses of inhalation 
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injury were 93% and 96% accurate, respectively.55,65 However, as useful abnormal findings 
often cannot be measured for several hours postinjury using this method, the delay required 
may result in the initiation of treatment too late for optimal management.59 Gammagram 
using nebulized technetium-99 has also been used to confirm the diagnosis of inhalation 
injury.66 While highly sensitive, it is not in wide clinical use due to expense, time to acquire 
the radionuclide, and other logistic difficulties.67,68 Another diagnostic adjunct is the chest 
X-ray. A chest X-ray taken at admission best serves as a baseline for comparison to 
subsequent ones. A normal chest X-ray on hospital day 1 does not preclude a diagnosis of 
inhalation injury as pathophysiologic changes may take hours to become apparent in a 
radiograph.54 However, pulmonary infiltrates may indicate severe inhalation injury and 
susceptibility to significant morbidities.69 Chest tomography (CT) may supplement 
bronchoscopy as well as to grade injury. This adjunct allows the clinician to assess damage 
to smaller airways. Such damage cannot be assessed by bronchoscopy, which provides views 
of only the proximal airway.70 This handicap to FOB has been theorized as an explanation 
for the discrepancy between mortality and bronchoscopic-determined severity of injury.57 In 
assessing the bronchial-wall thickness at admission, one study found that CT measurement 
significantly correlates to the number of ventilator and ICU days, and the development of 
pneumonia.71 Various approaches have shown utility of a CT scan, but timing of scans and 
interpretation of findings remain controversial.70,72
Systemic Poisoning
Systemic injury occurs when the toxic compounds such as CO or cyanide are inhaled and 
enter the blood. Due to non-specific clinical symptoms, this condition may be dismissed, 
leading to negative outcomes, including death. Carbon monoxide intoxication can be quickly 
measured with a pulse CO-oximeter. A newer diagnostic adjunct, it is not readily available at 
many centers. Laboratory work can take too long, and delays in transfer as well as 
supplemental oxygen prophylactically given to patients suspected to have inhalation injury 
can lower carboxyhemoglobin (COHb) concentrations. As COHb levels may not correlate to 
the degree of poisoning, injury history and physical examinations are vital diagnostic tools 
in the setting of carbon monoxide intoxication. Given the half-life of cyanide and no rapid 
method by which to detect it in the blood, diagnosis of cyanide poisoning largely rests on 
findings of lactic acidosis and a carboxyhemoglobin concentration greater than 10% as well 
as abnormal hemodynamics and a Glasgow Coma Scale less than 14.7
GRADING SCHEME
Currently, a multicenter study to determine a grading scheme for inhalation injury based on 
clinical, bronchoscopic, biochemical, and radiographic findings is underway 
(ClinicalTrials.gov identifier NCT01194024). As no such study has transpired prior, no 
consensus exists as to a scoring system. The Abbreviated Injury Score corresponds with an 
increase in impaired gas exchange and mortality73. However, studies have found that the 
PaO2/FiO2 ratio a more reliable indicator of inhalation injury severity. Yet, this grading 
utility is impacted by the ventilator settings, and it may be affected by resuscitation volume.
73,74
 At Shriners Hospitals for Children – Galveston, we grade the severity as mild, 
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moderate or severe based on bronchoscope findings of erythema, secretion, casts, and 
epithelial sloughing.
TREATMENT
Supraglottic
The primary treatment for a supraglottic inhalation injury compromising the airway is 
orotracheal or nasotracheal intubation. Most intubations occur prior to arrival at the burn 
center by personnel inexperienced in the management of burn patients.75 Early intubation 
patients are those who receive supplemental oxygen and present with respiratory distress or 
hypoxemia or with signs of upper airway compromise, such as mucosal edema, erythema, 
stridor or hoarseness.
Data conflict over the appropriateness of early intubation in burn patients. Pulmonary 
function tests have been investigated for their utility in identifying need for intubation, but 
the results did not match the clinical status of the patient.76 In a retrospective study 
evaluating the efficacy of prehospital intubations, it was shown that of 879 patients, only 
11.9% were extubated within 24 hours of admission once inhalation injury was excluded by 
FOB.77 In a recent large study series, more than 33% of burn patients were extubated within 
1 day of intubation without reintubation following transfer to a burn center.75 In a smaller 
series, 53% of burn patients were extubated on hospital day 1 and almost 65% by hospital 
day 278. Given the many and various complications that can arise from intubations (e.g., 
atelectasis, ventilator-associated pneumonia, lost airway, tracheal injury, death), the risk to 
the patient may outweigh the reward.79 In general, intubation is indicated to improve 
ventilation or oxygenation, or to maintain a compromised airway (Table 2). The best 
approach is to keep the airway patent until an experienced practitioner can perform FOB and 
then determine if the tube should be removed.
Maintaining an ETT on a burned face is a significant challenge and accidental extubation is 
a concern. However, many solutions have been developed. A large survey of American burn 
centers reported ETTs secured with linen non-adhesive tape in 59% of cases, manufactured 
devices in 48%, and orthodontic in 24%.80 Septal ties have been utilized to secure nasal 
intubations at Shriners Hospitals for Children® – Galveston for 20 years without accidental 
extubation or septic sinusitis complications.81 Tracheotomy delivers a durable airway long-
term with increased patient comfort. The survey of American burn centers also reported the 
average tracheotomy is performed at 2 weeks. Despite a consensus that indications exist for 
earlier tracheotomies,80 Terragni et al. found ventilator and ICU days were reduced but no 
significant improvement in ventilator-associated pneumonia from early tracheotomy in a 
study of 600 adult ICU patients.82
When possible, the patient should receive humidified oxygen to prevent secretions from 
thickening. The head of the bed should be elevated 45 degrees to reduce supraglottic edema 
and minimize the pressure exerted by the intra-abdominal structures when the patient is 
lying flat, and judicious use of steroids and/or diuretics may be helpful.83
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Subglottic
Management of subglottic inhalation injuries is directed at the principle pathophysiologies, 
particularly mucosal hyperemia and edema, bronchospasm, expectoration of mucous and 
casts, and improving V/Q ratio. Care must be taken to limit further harm such as ventilator-
induced injury through excessive pressure (barotrauma), which may be as severe as a tension 
pneumothorax and, ultimately, life-threatening.
Management of airway hyperemia is currently in preclinical studies. Reduction of airway 
blood flow through bronchial artery ligation has demonstrated significant improvements in 
many variables, including reduction in transvascular fluid flux (lymph flow).19,84–87 Studies 
in animal models of inhalation injury showed that bronchial artery ligation diminishes 
edema.19,88 Occlusion of the bronchial artery reduces chemokine levels.85–87 These studies 
support the use of nebulized agents for treating inhalation injury, especially agents that may 
reduce edema. While many practitioners endeavor to reduce airway edema by restricting 
fluid resuscitation, patients with inhalation injury require more intravenous fluid for 
resuscitation than predicted by resuscitation formulas,89 which only consider the percent of 
cutaneous burn. In a preclinical inhalation injury model, fluid restriction exacerbates 
pulmonary capillary leak and increases lung lymph formation.90 Fluid restriction can lead to 
hypoperfusion, shock, and death, while fluid overload can result in pulmonary edema, right 
heart failure, compartment syndromes, shock, and death.91 Several burn resuscitation 
formulas can be used to estimate fluid requirements for 24–48 hours post-burn. The rate of 
the fluid administration requires titration, which can lead to error and suboptimal outcomes. 
Resultantly, computerized decision support systems have been developed to assist the burn 
surgeon in fluid resuscitation management. In burn patients, these systems have yielded 
satisfactory results, with sufficient fluid being administered to patients during resuscitation.
92,93
 Regardless of the fluid resuscitation formula employed, the patient should be 
resuscitated sufficiently to a selected end point and care taken to avoid fluid overload or 
underload.
Bronchoalveolar lavage is the washing of lung segments often utilized to diagnose infections 
but does have therapeutic relevance, particularly whole-lung lavage.94,95 Saline is used to 
flush the contaminant materials from the lung until the fluid runs clear.96 In reviewing data 
from the National Burn Repository, Carr and colleagues determined that burn patients with 
inhalation injury complicated by pneumonia who underwent at least one bronchoscopic 
procedure had significantly shorter stays in ICUs and hospitals, reduced hospital costs, and a 
mortality risk reduced by 18% as compared to burn patients who did not undergo a 
bronchoscopic procedure.97 Patients with less than 60% TBSA burn who underwent at least 
one bronchoscopic procedure had decreased days on mechanical ventilation, leading Carr 
and coworkers to conclude bronchoscopy may be indicated following inhalation injury.97
Concerningly, airway pressure may rise to dangerous levels if high tidal volume ventilation 
is initiated; the probability of tension pneumothorax is latent in this scenario.98 
Overdistention of the airway stimulates the release of multiple pro-inflammatory cytokines 
such as interleukin-8, a powerful neutrophil chemotactic factor. This results in even greater 
injury to the pulmonary tissue cells by the inducement of iNOS that serves to increase 
production of reactive oxygen species, which overpower the native defenses of the body.57,99 
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Therefore, removal of these obstructive casts by medical intervention is vital. However, casts 
may be lodged in the alveoli, making it difficult or impossible to extract them using 
mechanical methods such as bronchoalveolar lavage.
Breaking down airway casts and augmenting expectoration comprise the core of managing 
subglottic inhalation injury. Nebulized fibrinolytics have been evaluated in preclinical 
inhalation injury models with promising results.100 Fibrin casts are broken down with 
nebulized heparin.101,102 Heparin prevents coagulation of transudated plasma leaking from 
injured pulmonary capillaries.5,103 With sloughed mucosa, mucus portions of casts are 
fragmented by n-acetylcysteine acting as a mucolytic agent and permitting expectoration.104 
N-acetylcysteine has been shown safe and efficacious.105 This combination, nebulized N-
acetylcysteine and heparin with albuterol and pulmonary toileting, is a common protocol to 
treat inhalation injury.104 It serves to mediate the cell injury incited by reactive oxygen 
species induced by iNOS.57 Despite noted methodological issues, a meta-analysis 
comprising 286 burn patients determined inhaled heparin reduced ventilator days and 
resulted in more patients alive at day 28 with lower lung injury scores.106 In a nonburned 
population, Kashefi and colleagues found an increase in pneumonia rates and no reduction in 
mortality or mechanical ventilation days from a nebulized heparin and N-acetylcysteine/
albuterol regimen, highlighting the distinct pathology of inhalation injury.107 Conversely, a 
recently published case-control study of 72 inhalation injured burn patients demonstrated a 
7-day course of nebulized heparin with N-acetylcysteine and albuterol increased ventilator-
free days and decreased average ventilator days from 14 to 7. There was no increase in 
mortality, pneumonia rates, or bleeding in this study, and nebulized heparin was found safe 
and effective.104 This efficacy is consistent with the clinical experience treating burn patients 
at Shriners Hospitals for Children – Galveston.
Bronchospasm is treated with nebulized bronchodilators. Nebulized epinephrine has been 
tested in the preclinical setting with satisfactory results by reducing airway pressure and 
increasing distensibility through its β2-agonist effects, causing bronchodilation in models of 
inhalation injury with cutaneous burns.108 Administration of nebulized albuterol or 
nebulized epinephrine produces immediate effects, provoking bronchodilation and reducing 
airway pressure. Bronchodilators are also needed when administering N-acetylcysteine due 
to its potent respiratory irritant profile.
Injured lungs must clear secretions, damaged mucosa, pathogens, and aspirated material. In 
the case of compromised mucociliary escalators, transudates of fibrinous material and 
mucosal slough must be expectorated. Bronchoscopy, mucolytics, suctioning, chest 
physiotherapy, and specific ventilator modes assist in lung expectoration.109 Airway 
suctioning should be performed when needed. If done incautiously, the patient may become 
hypoxic and bradycardic due to vagal stimulation. Therefore, pre-oxygenation is advisable 
prior to suction, and suctioning should be done for up to 10 seconds. Chest physiotherapy, 
including percussive and coughing techniques, should be performed, along with early 
mobilization. Postural drainage is recommended and should be done when possible.110 
Collectively, these techniques prevent the accumulation of secretions, which may cause 
airway obstruction and atelectasis and potentiate pneumonias.111,112 Clearance of secretions 
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can be eased by chest percussion and vibration such as high-frequency chest wall oscillation.
113
Burn patients present considerable challenges in mechanical ventilation and ARDS from 
elevated carbon dioxide production because of the hypermetabolic response, perturbed 
physiology from inhalation injury, reduced compliance from eschar, and pulmonary edema 
from resuscitation. Ventilator management is centered on ensuring sufficient oxygenation 
and ventilation and optimizing expectoration, balanced against avoiding second-hit injuries 
that can incite ARDS. ARDSnet studies demonstrated that ventilator-associated injuries to 
lungs can trigger ARDS and appreciably affect morbidity and mortality. While ARDSnet 
upholds utilizing low tidal volume (LTV), these protocols are ineffectual among burn 
patients; 33% failed to meet ventilation and oxygenation goals, increasing to about 67% with 
concomitant inhalation injury.80 Furthermore, the work required to breathe intensifies 
progressively at low tidal volumes.114 Investigating pulmonary outcomes in 932 burned 
pediatric patients with inhalation injury over 28 years, Sousse and colleagues concluded that 
high tidal volume (15+/−3 ml/kg) corresponds with considerably decreased ventilator days 
and ARDS, maximum positive end-expiratory pressure, significantly increased maximum 
peak inspiratory pressure, and increased pneumothorax. They determined that high tidal 
volumes might disrupt the cascade of events leading to lung injury following inhalation 
injury.115
Both volume and pressure-cycled modes are in common use, though the optimal ventilator 
mode in inhalation injury remains controversial. The open lung strategies airway pressure-
release ventilation (APRV) and high-frequency percussive ventilation (HFPV) augment 
impaired oxygenation and buttress expectoration and are becoming the standard modes for 
more burn centers.
APRV provides unceasing positive airway pressure with a time-cycled pressure-release 
phase to permit ventilation and expectoration. Keeping pressures elevated in the airways for 
most of the respiratory cycle, this facilitates improved V/Q ratio, extensive alveolar 
recruitment permitting an open lung, and very high MAP-O2 to overpower high A-a 
gradients.116
A time-cycled mode, HFPV delivers subtidal pressure-limited breaths at high frequencies 
(400–800 beats/min) superimposed on a conventional inspiratory and expiratory pressure-
controlled cycle (10–30 breaths/min). This purportedly mobilizes airway secretions and 
casts, facilitating improved expectoration and pulmonary toilet, and provides adequate gas 
exchange at lower airway pressures. First reported in 1989, HFPV has been tested primarily 
in burned patients with inhalation injury.117 In this study, HFPV was used as a salvage 
therapy in one group of burned patients with inhalation injury and as the primary therapy in 
another group. Improvements in oxygenation and a lower rate of pneumonia were seen. A 
subsequent study documented an improvement in mortality in burned patients with 
inhalation injury treated with HFPV compared to historical controls as well as significant 
decreases in the work of breathing and lower inspiratory pressures in addition to 
improvements in oxygenation and the rate of pneumonia.118 However, some studies have 
reported no statistically significant differences between pressure-limited strategies versus 
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conventional modes in various outcomes (e.g., mortality, pulmonary complications, 
inflammatory markers) except in barotrauma and improved oxygenation.119, 120 In the trial 
comparing HFPV to an ARDSnet-based conventional strategy, a lower incidence of 
barotrauma was seen in the HFPV group, improved oxygenation early and less rescue 
needed.120 While the efficacy is debated, these data mostly support HFPV as a useful 
adjunct in managing burn patients.
Systemic
Treatment for CO and cyanide intoxication is urgent since these can cause systemic toxicity 
and can be rapidly fatal. Intoxication should be suspected and ruled out in all patients with 
intense smoke exposure. When carboxyhemoglobin levels exceed 10%, 100% oxygen 
should be administered via a tightly-fitting high flow mask or endotracheal tube.121 On 
100% oxygen, the half-life of the carboxyhemoglobin was reduced to 74 ± 25 minutes from 
4–6 hours.122,123 Measurement of carboxyhemoglobin on ABG can quantify CO quickly. 
Real-time assessment via pulse CO-oximetry is available but not widely adopted.124 
Controversy exists regarding the use of hyperbaric oxygen in these patients.125 Additionally, 
hyperbaric chambers are not always available and can be costly. However, in patients whose 
carboxyhemoglobin levels remain high following administration of oxygen or whose mental 
status deteriorates, hyperbaric oxygen therapy may be indicated.126 A 25% reduction in the 
incidence of long-term neurological sequelae was reported in patients receiving hyperbaric 
oxygen therapy as compared to patients receiving other treatments.127 Further, this adjunct 
has been shown to allay the inflammatory processes provoked by CO poisoning.126 
However, this must be balanced against other critical care needs.
Cyanide is often present in smoke, particularly when the combustible is plastic. 
Hydroxocobalamin, the precursor of vitamin B12, is a safe treatment with few side effects. 
Sulfur donors such as sodium thiosulfate accentuate the conversion of cyanide to 
thiocyanate, reducing its toxicity.128 However, a Task Force of the European Centre for 
Ecotoxicology and Toxicology of Chemicals determined hydroxocobalamin to be the 
preferred adjunct to treat cyanide intoxication from smoke inhalation rather than sodium 
thiosulfate or sodium nitrite.93 Treating cyanide poisoning can be an indirect therapy of 
carbon monoxide intoxication because of the synergistic toxicities of the molecules, thereby 
shortening the duration of oxygen administration.
CONCLUSION
Inhalation injuries increase burn mortality through heterogeneous injuries. Limited number 
of treatment modalities and the lack of a clear diagnostic criteria or grading system to direct 
therapeutic modalities stymie medical professionals in assessing and managing inhalation 
injury. This, in turn, has prevented continued significant improvements in this coincident 
pathology of thermal injury, explaining the high mortality rates resulting from inhalation 
injury in burn patients.129 Further clinical study is required to address this grave condition to 
better serve this patient population.
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Figure 1. 
Bronchoscopic image of trachea in inhalation injury.
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Table 1
Evidence-based treatment protocol for patients with smoke inhalation injury at Shriners Hospitals for 
Children® at Galveston
• Nebulize 20% N-acetylcysteine (3 mL) every 4 hours for 7 days;
• Alternate aerosolizing 10,000 units of heparin (in 3 mL normal saline) every 4 hours for 7 days
• Nebulize with albuterol in case of wheezing
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Table 2
Guidelines for intubation in the pre-burn center setting. Courtesy of Romanowski KS, Palmieri TL, Sen S, 
Greenhalgh DG. More than one third of intubations in patients transferred to burn centers are unnecessary: 
Proposed guidelines for appropriate intubation of the burn patient. J Burn Care Res. 2015;37(5):e409-14.
Guidelines for intubation in the pre-burn center setting
• Patient safety should not be compromised, and patient status is the ultimate determinant of intubation need
• Standard indications for intubation should be followed, including but not limited to shortness of breath, wheezing, stridor, 
hoarseness, combativeness, or decreased level of consciousness
• Contact should be made with the regional burn center as soon as is safely feasible to discuss the events surrounding the burn and 
need for intubation
• If the patient is clinically stable with no signs or symptoms of compromised airway, burns with lower need for intubation before 
transfer to a burn center are as follows:
◦ Burns that occur from causes other than flame injury
◦ Burns that do not occur in enclosed spaces
◦ Burns that are less than 20% total body surface area
◦ Burns that have no third degree burns to the face
◦ Patient is within a reasonable distance to a burn center (approximately 3-hour transfer time)
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